Oral Question·Department for Levelling Up, Housing and Communities
“If he will make a statement on his departmental responsibilities.”
Tabled: 10 May 2022Answered: 16 May 2022
Answering Minister
the Secretary of State for Levelling Up, Housing and Communities
Answer from Hansard
The Minister for Care (Stephen Kinnock)
I thank my hon. Friend for that question and welcome him to his place. This issue is personal for me, and I am sure it is for many others across this House. A number of potential new disease-modifying drugs for Alzheimer’s are in the pipeline, including lecanemab and donanemab. We are committed to ensuring that clinically effective and cost-effective medicines reach patients in a timely and safe way. The National Institute for Health and Care Excellence is appraising lecanemab and donanemab to determine whether they will be made available in the NHS.